Concurrent mutation of EZH2 and the transcription factor RUNX1 is a relatively common event in ETP-ALL [5]; experimental data in normal ETP showed that inactivation of either of the two genes did not affect cell development, whereas inactivation of both genes resulted in expansion of the ETP pool and blocked differentiation [19]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.